These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 28910894

  • 1. [Diagnostic values of BRAF(V600E) mutation analysis and Bethesda system for reporting thyroid cytopathology in thyroid nodules with TIRADS 4 and 5].
    Han Y, Zhao BW, Li SY, Lyu JG, Shou JD, Xu HS, Lou HY, Xu LL, Gao L, Xu SX, Zhu J.
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Sep 07; 52(9):686-691. PubMed ID: 28910894
    [Abstract] [Full Text] [Related]

  • 2. Value of TIRADS, BSRTC and FNA-BRAF V600E mutation analysis in differentiating high-risk thyroid nodules.
    Zhang YZ, Xu T, Cui D, Li X, Yao Q, Gong HY, Liu XY, Chen HH, Jiang L, Ye XH, Zhang ZH, Shen MP, Duan Y, Yang T, Wu XH.
    Sci Rep; 2015 Nov 24; 5():16927. PubMed ID: 26597052
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Significance of FNAC, BRAF mutation, and intraoperative frozen section in surgical decision-making of thyroid nodules.
    Zhu Z, Su C, Chen G, Wan F, Jin M, Duan X, Wang Y, Wang G.
    Diagn Cytopathol; 2023 Jul 24; 51(7):441-448. PubMed ID: 37042168
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Diagnostic Efficacy of Ultrasound, Cytology, and BRAFV600E Mutation Analysis and Their Combined Use in Thyroid Nodule Screening for Papillary Thyroid Microcarcinoma.
    Du J, Han R, Chen C, Ma X, Shen Y, Chen J, Li F.
    Front Oncol; 2021 Jul 24; 11():746776. PubMed ID: 35047385
    [Abstract] [Full Text] [Related]

  • 7. BRAF V600E mutation and the Bethesda System for Reporting Thyroid Cytopathology of fine-needle aspiration biopsy for distinguishing benign from malignant thyroid nodules.
    Sheng D, Yu X, Li H, Zhang M, Chen J.
    Medicine (Baltimore); 2021 Sep 17; 100(37):e27167. PubMed ID: 34664843
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Value of BRAF V600E in High-Risk Thyroid Nodules with Benign Cytology Results.
    Chen X, Zhou Q, Wang F, Zhang F, Du H, Zhang Q, Wu W, Gong X.
    AJNR Am J Neuroradiol; 2018 Dec 17; 39(12):2360-2365. PubMed ID: 30498021
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Initial clinical experience with BRAF(V600E) mutation analysis of core-needle biopsy specimens from thyroid nodules.
    Choi SH, Baek JH, Lee JH, Choi YJ, Ha EJ, Song DE, Kim JK, Chung KW, Kim TY, Kim WB, Shong YK.
    Clin Endocrinol (Oxf); 2016 Apr 17; 84(4):607-13. PubMed ID: 26215382
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cytomorphologic features in thyroid nodules read as "suspicious for malignancy" on cytology may predict thyroid cancers with the BRAF mutation.
    Kwon HJ, Kim EK, Kwak JY.
    Pathol Res Pract; 2015 Sep 17; 211(9):671-6. PubMed ID: 26187369
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The Combined Use of Fine-Needle Aspiration (FNA) and BRAF V600E Gene Testing: Can it Increase the Definitive Diagnosis Rate of Nodules Categorized as Bethesda III for Papillary Thyroid Carcinoma?
    Lei L, Hong Qing S, Wei L, Ma Mo Yang F, Xiao Xiang Y.
    Am Surg; 2024 Dec 17; 90(12):3209-3215. PubMed ID: 39047144
    [Abstract] [Full Text] [Related]

  • 17. Role of ultrasonographic/clinical profile, cytology, and BRAF V600E mutation evaluation in thyroid nodule screening for malignancy: a prospective study.
    Rossi M, Buratto M, Bruni S, Filieri C, Tagliati F, Trasforini G, Rossi R, Beccati MD, Degli Uberti EC, Zatelli MC.
    J Clin Endocrinol Metab; 2012 Jul 17; 97(7):2354-61. PubMed ID: 22535974
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma.
    Paek SH, Kim BS, Kang KH, Kim HS.
    World J Surg Oncol; 2017 Nov 13; 15(1):202. PubMed ID: 29132392
    [Abstract] [Full Text] [Related]

  • 20. BRAFV600E mutation testing in fine needle aspirates of thyroid nodules: potential value of real-time PCR.
    Kwak JY, Han KH, Yoon JH, Kim EK, Moon HJ, Kim YL, Park SJ, Choi JR.
    Ann Clin Lab Sci; 2012 Nov 13; 42(3):258-65. PubMed ID: 22964613
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.